UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 165

Sortiert nach

Alzheimer’s disease treatment with Transcranial Pulse Stimulation using shockwave pulses is increasingly successful: Patient’s feedback is very positive

Alzheimer's & dementia, 2022-12, Vol.18 (S8), p.n/a

Novak, Pavel

2022

Link zum Volltext

Verfügbarkeit prüfen

Significant reduction of Alzheimer’s disease symptoms by transcranial pulse stimulation, TPS: Dementia care research (research projects; nonpharmacological)/Therapeutic strategies and interventions

Alzheimer's & dementia, 2020-12, Vol.16 (S7)

Novak, Pavel

2020

Link zum Volltext

Verfügbarkeit prüfen

Significant reduction of Alzheimer’s disease symptoms by transcranial pulse stimulation, TPS

Alzheimer's & dementia, 2020-12, Vol.16, p.n/a

Novak, Pavel

2020

Link zum Volltext

Verfügbarkeit prüfen

FIRST-IN-MAN AND FIRST-IN-CLASS TAU VACCINE

Alzheimer's & dementia, 2014-07, Vol.10 (4), p.P162-P162

Novak, Michal

2014

Link zum Volltext

Verfügbarkeit prüfen

F2‐04‐04: FIRST‐IN‐MAN AND FIRST‐IN‐CLASS TAU VACCINE

Alzheimer's & dementia, 2014-07, Vol.10 (4S_Part_2), p.P162-P162

Novak, Michal

2014

Link zum Volltext

Verfügbarkeit prüfen

The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partners Scientific Board (PPSB)

Alzheimer's & dementia, 2024-01, Vol.20 (1), p.695-708

2024

Link zum Volltext

Verfügbarkeit prüfen

CHARACTERISATION OF THE ANTIBODY RESPONSE TO AADVAC1: THE FIRST-IN-KIND ACTIVE VACCINE AGAINST NEUROFIBRILLARY TAU PATHOLOGY

Alzheimer's & dementia, 2016-07, Vol.12 (7), p.P351-P351

2016

Link zum Volltext

Verfügbarkeit prüfen

O4‐08‐01: Characterisation of the Antibody Response to AADVAC1: The First‐in‐Kind Active Vaccine Against Neurofibrillary TAU Pathology

Alzheimer's & dementia, 2016-07, Vol.12 (7S_Part_7), p.P351-P351

2016

Link zum Volltext

Verfügbarkeit prüfen

The ADAS-Cog revisited: Novel composite scales based on ADAS-Cog to improve efficiency in MCI and early AD trials

Alzheimer's & dementia, 2013-02, Vol.9 (1), p.S21-S31

2013

Link zum Volltext

Verfügbarkeit prüfen

P2‐431: NEUROPATHOLOGY OF EARLY‐ONSET FAMILIAL ALZHEIMER'S DISEASE CAUSED BY PRESENILIN‐1 MISSENSE MUTATION THR116ASN

Alzheimer's & dementia, 2019-07, Vol.15 (7S_Part_15), p.P777-P778

2019

Link zum Volltext

Verfügbarkeit prüfen

NEUROPATHOLOGY OF EARLY-ONSET FAMILIAL ALZHEIMER’S DISEASE CAUSED BY PRESENILIN-1 MISSENSE MUTATION THR116ASN

Alzheimer's & dementia, 2019-07, Vol.15 (7), p.P777-P778

2019

Link zum Volltext

Verfügbarkeit prüfen

Tau transgenic rat model and response to tau vaccine

Alzheimer's & dementia, 2010-07, Vol.6 (4), p.S118-S118

Novak, Michal

2010

Link zum Volltext

Verfügbarkeit prüfen

F3‐02‐03: Tau transgenic rat model and response to tau vaccine

Alzheimer's & dementia, 2010-07, Vol.6 (4S_Part_4), p.S118-S118

Novak, Michal

2010

Link zum Volltext

Verfügbarkeit prüfen

PREDICTING CHANGE IN HIPPOCAMPAL VOLUME USING MRI FEATURES FROM BASELINE

Alzheimer's & dementia, 2016-07, Vol.12 (7), p.P550-P551

2016

Link zum Volltext

Verfügbarkeit prüfen

Tau immunotherapy: The way to crack the immune code of misfolded protein tau

Alzheimer's & dementia, 2013-07, Vol.9 (4), p.P674-P674

2013

Link zum Volltext

Verfügbarkeit prüfen

S4–02–02: Tau immunotherapy: The way to crack the immune code of misfolded protein tau

Alzheimer's & dementia, 2013-07, Vol.9 (4S_Part_17), p.P674-P674

2013

Link zum Volltext

Verfügbarkeit prüfen

O4‐04‐06: The First Tau Vaccine for Therapy of Alzheimer's Disease and FTLD: From Tau Structure to Human Clinical Trials

Alzheimer's & dementia, 2016-07, Vol.12 (7S_Part_7), p.P341-P341

2016

Link zum Volltext

Verfügbarkeit prüfen

THE FIRST TAU VACCINE FOR THERAPY OF ALZHEIMER'S DISEASE AND FTLD: FROM TAU STRUCTURE TO HUMAN CLINICAL TRIALS

Alzheimer's & dementia, 2016-07, Vol.12 (7), p.P341-P341

2016

Link zum Volltext

Verfügbarkeit prüfen

NEUROPATHOLOGY OF EARLY-ONSET FAMILIAL ALZHEIMER'S DISEASE CAUSED BY PRESENILIN-1 MISSENSE MUTATION THR116ASN

Alzheimer's & dementia, 2018-07, Vol.14 (7), p.P521-P521

2018

Link zum Volltext

Verfügbarkeit prüfen

P1‐500: NEUROPATHOLOGY OF EARLY‐ONSET FAMILIAL ALZHEIMER'S DISEASE CAUSED BY PRESENILIN‐1 MISSENSE MUTATION THR116ASN

Alzheimer's & dementia, 2018-07, Vol.14 (7S_Part_9), p.P521-P521

2018

Link zum Volltext

Verfügbarkeit prüfen

Application of the Preclinical Alzheimer’s Cognitive Composite for tracking progression in cognitively unimpaired older adults with known Amyloid status: A 24‐month Interim Analysis of the Chariot‐Pro cohort

Alzheimer's & dementia, 2022-12, Vol.18 (S7), p.n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

Multivariate prediction of change in hippocampal volume in Alzheimer’s disease

Alzheimer's & dementia, 2015-07, Vol.11 (7), p.P807-P808

2015

Link zum Volltext

Verfügbarkeit prüfen

Clinical characteristics of subjects with conflicting biomarkers of amyloid deposition

Alzheimer's & dementia, 2015-07, Vol.11 (7), p.P535-P536

2015

Link zum Volltext

Verfügbarkeit prüfen

S2‐01‐02: Tau vaccine: Active immunization with misfolded tau protein attenuates tau pathology in the transgenic rat model of tauopathy

Alzheimer's & dementia, 2009-07, Vol.5 (4S_Part_3), p.P93-P93

Novak, Michal

2009

Link zum Volltext

Verfügbarkeit prüfen

Tau vaccine: Active immunization with misfolded tau protein attenuates tau pathology in the transgenic rat model of tauopathy

Alzheimer's & dementia, 2009-07, Vol.5 (4), p.P93-P93

Novak, Michal

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 165

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieAlzheimer's & Dementia

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(165)
Mit Volltextzugriff
(165)

Publikationsform

Artikel
(165)

Sprache

Englisch
(165)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Neurology
(69)
Clinical Neurology
(5)
Humans
(5)
Life Sciences & Biomedicine
(5)
Neurosciences & Neurology
(5)
Science & Technology
(5)
Alzheimer Disease - Diagnosis
(3)
Alzheimer's Disease Neuroimaging Initiative
(3)
Aged
(2)
Alzheimer's Disease
(2)
Clinical Trials
(2)
Clinical Trials As Topic
(2)
Female
(2)
Male
(2)
Mild Cognitive Impairment
(2)
Neuroimaging
(2)
Neuroimaging - Methods
(2)
Adas-Cog
(1)
Adas‐cog
(1)
Adni
(1)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Wiley Online Library Journals Frontfile Complete
(165)
Journals@Ovid Complete
(165)
Ingenta
(165)
Elsevier ScienceDirect Journals Complete
(165)
IngentaConnect Journals
(69)
MEDLINE
(5)
Applied Social Sciences Index & Abstracts (ASSIA)
(1)

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Alzheimer’s disease treatment with Transcranial Pulse Stimulation using shockwave pulses is increasingly successful: Patient’s feedback is very positive

Significant reduction of Alzheimer’s disease symptoms by transcranial pulse stimulation, TPS: Dementia care research (research projects; nonpharmacological)/Therapeutic strategies and interventions

Significant reduction of Alzheimer’s disease symptoms by transcranial pulse stimulation, TPS

FIRST-IN-MAN AND FIRST-IN-CLASS TAU VACCINE

F2‐04‐04: FIRST‐IN‐MAN AND FIRST‐IN‐CLASS TAU VACCINE

The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partners Scientific Board (PPSB)

CHARACTERISATION OF THE ANTIBODY RESPONSE TO AADVAC1: THE FIRST-IN-KIND ACTIVE VACCINE AGAINST NEUROFIBRILLARY TAU PATHOLOGY

O4‐08‐01: Characterisation of the Antibody Response to AADVAC1: The First‐in‐Kind Active Vaccine Against Neurofibrillary TAU Pathology

The ADAS-Cog revisited: Novel composite scales based on ADAS-Cog to improve efficiency in MCI and early AD trials

P2‐431: NEUROPATHOLOGY OF EARLY‐ONSET FAMILIAL ALZHEIMER'S DISEASE CAUSED BY PRESENILIN‐1 MISSENSE MUTATION THR116ASN

NEUROPATHOLOGY OF EARLY-ONSET FAMILIAL ALZHEIMER’S DISEASE CAUSED BY PRESENILIN-1 MISSENSE MUTATION THR116ASN

Tau transgenic rat model and response to tau vaccine

F3‐02‐03: Tau transgenic rat model and response to tau vaccine

PREDICTING CHANGE IN HIPPOCAMPAL VOLUME USING MRI FEATURES FROM BASELINE

Tau immunotherapy: The way to crack the immune code of misfolded protein tau

S4–02–02: Tau immunotherapy: The way to crack the immune code of misfolded protein tau

O4‐04‐06: The First Tau Vaccine for Therapy of Alzheimer's Disease and FTLD: From Tau Structure to Human Clinical Trials

THE FIRST TAU VACCINE FOR THERAPY OF ALZHEIMER'S DISEASE AND FTLD: FROM TAU STRUCTURE TO HUMAN CLINICAL TRIALS

NEUROPATHOLOGY OF EARLY-ONSET FAMILIAL ALZHEIMER'S DISEASE CAUSED BY PRESENILIN-1 MISSENSE MUTATION THR116ASN

P1‐500: NEUROPATHOLOGY OF EARLY‐ONSET FAMILIAL ALZHEIMER'S DISEASE CAUSED BY PRESENILIN‐1 MISSENSE MUTATION THR116ASN

Application of the Preclinical Alzheimer’s Cognitive Composite for tracking progression in cognitively unimpaired older adults with known Amyloid status: A 24‐month Interim Analysis of the Chariot‐Pro cohort

Multivariate prediction of change in hippocampal volume in Alzheimer’s disease

Clinical characteristics of subjects with conflicting biomarkers of amyloid deposition

S2‐01‐02: Tau vaccine: Active immunization with misfolded tau protein attenuates tau pathology in the transgenic rat model of tauopathy

Tau vaccine: Active immunization with misfolded tau protein attenuates tau pathology in the transgenic rat model of tauopathy

Aktive Filter

Suchergebnisse filtern